Not a good buy right now for an impatient buyer: price is extended/overbought while sitting at/just above near-term resistance.
Trend is bullish (positive MACD, bullish moving averages), but risk/reward is unfavorable at this level; odds favor a pause/pullback rather than an immediate clean continuation.
Options sentiment is notably defensive (very high put/call ratios), and hedge funds have been selling heavily—both argue against chasing today.
Intellectia Proprietary Trading Signals: AI Stock Picker = no signal; SwingMax = no recent signal (no high-conviction “buy now” trigger from these modules).
Momentum: MACD histogram +0.679 and expanding → bullish momentum still present.
Overbought: RSI_6 = 86.815 → strongly overbought; near-term mean reversion risk is high.
Levels: Pivot 81.722; resistance R1 85.133 (price ~85.23, effectively testing/just over R1), next R2 87.24. Support S1 78.31.
Practical read: Strong uptrend, but entry here is “late” and vulnerable to a pullback toward the pivot/near 82 before becoming attractive again.
Options Data
Bearish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio
Positioning/Sentiment: Put open interest (357) far exceeds call open interest (79) → materially bearish/hedged stance.
Flow: Put/call volume ratio 2.5 on light total volume (14 contracts) but activity is elevated vs 30-day average (280%) → downside interest is showing up.
Volatility: IV (30d) 30.47 with very low IV percentile (7.57) / IV rank (4.87) → options are relatively cheap; the market is not pricing large swings even though positioning is defensive.
Technical Summary
Sell
5
Buy
10
Positive Catalysts
supports fundamental momentum.
Neutral/Negative Catalysts
at/near resistance increases probability of a near-term pullback.
flags competitive pressure and constrained valuation multiples.
Net income: $75.335M, +50.57% YoY (profitability improving faster than revenue).
EPS: $1.52, +28.81% YoY (solid per-share growth).
Summary: Fundamentally strong recent quarter, but the stock’s short-term technicals look stretched versus an attractive “buy now” entry.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent trend is mixed:
2026-02-02: Barclays downgraded to Underweight (from Equal Weight), PT stays $80; concern about competition and lower-for-longer valuation multiples.
2026-01-26: Keefe Bruyette raised PT to $96 (from $83) and kept Outperform.
2025-12-17: Barclays initiated Equal Weight, PT $80; noted repricing tailwinds but highlighted CRE concentration and integration risk.
Wall Street pros vs cons:
Pros: Repricing tailwinds, recent strong earnings growth, at least one notable bullish shop sees upside to mid/high-$90s.
Cons: Competitive pressures, valuation multiple ceiling, CRE/integration overhangs; latest Barclays action is a clear caution flag.
Wall Street analysts forecast INDB stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for INDB is 80.75 USD with a low forecast of 76 USD and a high forecast of 84 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Analyst Rating
Wall Street analysts forecast INDB stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for INDB is 80.75 USD with a low forecast of 76 USD and a high forecast of 84 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
2 Hold
0 Sell
Moderate Buy
Current: 85.170
Low
76
Averages
80.75
High
84
Current: 85.170
Low
76
Averages
80.75
High
84
Barclays
Equal Weight -> Underweight
downgrade
$80
AI Analysis
2026-02-02
Reason
Barclays
Price Target
$80
AI Analysis
2026-02-02
downgrade
Equal Weight -> Underweight
Reason
Barclays downgraded Independent Bank to Underweight from Equal Weight with an unchanged price target of $80. The firm says a "premium" is being placed on the bank's organic growth while competition is "heating up in its markets." Independent Bank's valuation multiples will remain below historical averages for the foreseeable future, the analyst tells investors in a research note.
Keefe Bruyette
NULL -> Outperform
maintain
$83 -> $96
2026-01-26
Reason
Keefe Bruyette
Price Target
$83 -> $96
2026-01-26
maintain
NULL -> Outperform
Reason
Keefe Bruyette raised the firm's price target on Independent Bank to $96 from $83 and keeps an Outperform rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for INDB